Trends in Complications and Outcomes in Patients Aged 65 Years and Younger Undergoing Total Knee Arthroplasty: Data From the American Joint Replacement Registry

医学 生存曲线 共病 查尔森共病指数 关节置换术 外科 单变量分析 回顾性队列研究 人口
作者
Akash Shah,David Alexander Cieremans,James Slover,Ran Schwarzkopf,Morteza Meftah
出处
期刊:Journal of the American Academy of Orthopaedic Surgeons [Wolters Kluwer]
卷期号:6 (6)
标识
DOI:10.5435/jaaosglobal-d-22-00116
摘要

The purpose of this study was to identify common complications and the rates of readmission and revision in total knee arthroplasty (TKA) patients younger than 65 years.Using the American Joint Replacement Registry, we conducted a retrospective review of all TKAs done in patients aged 18 to 65 years from 2012 to 2020. Demographic factors such as age, sex, Charlson Comorbidity Index (CCI), and preoperative Veterans RAND 12-Item Health Survey Physical Component Summary (VR-12 PCS) scores were collected. We excluded patients older than 65 years and revision, oncologic, and nonelective cases. Primary outcomes included cumulative revision rate, 90-day readmission rate, and reason for revision. Univariate analysis and the Kaplan-Meier method were used.Six thousand one hundred seventy-nine patients were included. The average age was 58.8 years (SD 5.5 years), 61% were female, 82% were White, and 88% had a CCI of 0 (1 = 8% and ≥2 = 4%). The mean follow-up was 42.51 months. Seventy-four patients (1.2%) underwent revision. Sixty-nine patients (1.1%) were readmitted within 90 days. No factors assessed increased revision rates. Revision-free survivorship was 98.7% (95% CI 98.4 to 99.0) and 98.6% (95% CI 98.2 to 99.0) at 5 and 8 years, respectively. Infection (15%), aseptic loosening (14%), and instability (12%) were the most common indications for revision.TKA done in young and presumed active patients has excellent survivorship. Long-term follow-up is needed to assess survival trends in this growing population.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
坂井泉水发布了新的文献求助20
刚刚
1秒前
1秒前
leizhengyu完成签到 ,获得积分10
2秒前
苻莞发布了新的文献求助10
2秒前
3秒前
胡呼呼完成签到,获得积分10
4秒前
6秒前
7秒前
8秒前
斩颓发布了新的文献求助10
8秒前
8秒前
完美世界应助早点睡觉丶采纳,获得10
9秒前
10秒前
张美发布了新的文献求助30
12秒前
12秒前
13秒前
发呆的小号完成签到 ,获得积分10
13秒前
橘子发布了新的文献求助10
13秒前
14秒前
bkagyin应助初七123采纳,获得10
14秒前
14秒前
15秒前
15秒前
15秒前
杯架发布了新的文献求助10
15秒前
哈哈哈哈完成签到,获得积分10
15秒前
15秒前
成德完成签到 ,获得积分10
16秒前
喜悦乐巧发布了新的文献求助10
16秒前
17秒前
17秒前
沉默甜瓜发布了新的文献求助10
18秒前
18秒前
beibei发布了新的文献求助10
19秒前
JayChou发布了新的文献求助10
20秒前
Akim应助ccc采纳,获得10
21秒前
闪闪的绣连完成签到,获得积分20
22秒前
lan发布了新的文献求助10
22秒前
结实晓蕾应助Nori采纳,获得10
23秒前
高分求助中
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Propeller Design 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Handbook of pharmaceutical excipients, Ninth edition 1500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6011376
求助须知:如何正确求助?哪些是违规求助? 7560434
关于积分的说明 16136728
捐赠科研通 5158063
什么是DOI,文献DOI怎么找? 2762650
邀请新用户注册赠送积分活动 1741401
关于科研通互助平台的介绍 1633620